HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 279322Generated: October 31, 2026
N-(2-((1-(4-chlorobenzyl)piperidin-4-yl)methylamino)-2-oxoethyl)-2-amino-5-(trifluoromethyl)benzamide → 4-[[N-(2-amino-5-trifluoromethylbenzoyl)glycyl]aminomethyl]piperidine
https://huagongshe.com/reaction/279322
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | N-(2-((1-(4-chlorobenzyl)piperidin-4-yl)methylamino)-2-oxoethyl)-2-amino-5-(trifluoromethyl)benzamide | HCID 9934977 | — |
| Catalyst | Palladium hydroxide | HCID 9942167 | — |
| Solvent | Formic acid methanol | HCID 18963719 | — |
| Product | 4-[[N-(2-amino-5-trifluoromethylbenzoyl)glycyl]aminomethyl]piperidine | HCID 18426227 | 86% |
Reaction Steps
A suspension of 1-(4-chlorobenzyl)-4-[{(N-(2-amino-5-trifluoromethylbenzoyl)glycyl)amino}methyl]piperidine (447 mg, 0.93 mmol) and Pd(OH)2 (60 mg, 0.23 mmol) in 5% HCO2H/methanol (10 mL) was stirred at 50° C. for 14 h. The Pd catalyst was filtered off through Celite, and the filtrate was concentrated. To the residue was added 1N aqueous NaOH solution (15 mL) and the mixture was extracted with ethyl acetate (30 mL×3). The combined extracts were dried over anhydrous sodium sulfate, filtered, and concentrated. Column chromatography (SiO2, AcOEt/MeOH/Et3N=70/25/5) gave 4-[{(N-(2-amino-5-trifluoromethylbenzoyl)glycyl)amino}methyl]piperidine (284 mg, 86%): ESI/MS m/e 359.0 (M++H, C16H21F3N4O2).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US06362177B1 |
|---|
| Source dataset | uspto-grants-2002_03 |
|---|
| ORD ID | ord-df42a15e4149489e81981255e6c06457 |
|---|
| Source note | uspto-grants-2002_03 |
|---|